
Nabilone safe and effective in pain reduction in combination with gabapentin compared to placebo
How to Cite
OrthoEvidence. Nabilone safe and effective in pain reduction in combination with gabapentin compared to placebo. ACE Report. 2018;7(9):26. Available from: https://myorthoevidene.com/AceReport/Report/10378
Nabilone as an adjunctive to gabapentin for multiple sclerosis-induced neuropathic pain: a randomized controlled trial
Pain Med. 2015 Jan;16(1):149-59. doi: 10.1111/pme.12569Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
Current convention in managing neuropathic pain (NPP) from relapsing-remitting multiple sclerosis (RRMS) often involves gabapentin (GBP) as first-line therapy and cannabis (CB) as an alternative, had other therapies not worked. The combination of GBP and CB has not been explored. In this study, 15 patients with NPP from RRMS and still experience considerable pain after a stable dosage of GBP were ...
To view the full report, start your 30-day free trial today
No credit card required
JOIN LOGIN Forgot Password?Not sure if you want to join OrthoEvidence?
Access this report without an Account.Success, an email containing a link to access this report has been sent to your inbox.
Explore some of our unlocked reports below!

Continuing Medical Education Credits
You could be earning 0.5 CME credits for each report you read.
LEARN MORE